2/19/2020 4:12:17 PM
Teva Says Registration Trials Of Deutetrabenazine In Pediatric Patients With Tourette Syndrome Did Not Meet Primary Goal
2/12/2020 7:03:23 AM
Teva Q4 Non-GAAP EPS $0.62 Vs $0.53 Last Year
2/3/2020 3:32:09 AM
Teva Announces Positive Top-Line Results From AJOVY Clinical Trials In Japan
1/28/2020 4:08:44 PM
Teva Says FDA Approved Autoinjector Device For AJOVY Injection
11/8/2019 9:47:02 AM
Teva Announces Launch Of $1.50 Bln Offering Of Senior Notes
11/8/2019 9:46:36 AM
Teva Announces $1.5 Bln Debt Tender Offers
11/7/2019 7:26:56 AM
Teva And Celltrion Announce Availability Of TRUXIMA Injection
11/7/2019 7:08:41 AM
Teva Pharma Appoints Eli Kalif As EVP And CFO
11/7/2019 7:06:33 AM
Teva Pharmaceutical Industries Limited (TEVA) Has Raised Its FY19 Revenue Estimate To $17.2 - $ 17.4 Bln From $17.0 - $ 17.4 Bln
11/7/2019 7:06:09 AM
Teva Pharmaceutical Industries Limited (TEVA) Has Raised Its FY19 EPS Estimate To 2.30 - 2.50 From 2.20 - 2.50
11/7/2019 7:03:02 AM
Teva Q3 Non-GAAP EPS $0.58 Vs $0.68 Prior Year